about
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionThe Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewFactors in AIDS dementia complex trial design: results and lessons from the abacavir trialCompartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementiaThe AIDS crisis: review of psychological issues and implications, with special reference to the South African situation.Pattern of neuropsychological performance among HIV positive patients in Uganda.Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.Timed Gait test: normative data for the assessment of the AIDS dementia complex.[CNS infections in immunocompromised patients].Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case reportAmyloid and tau cerebrospinal fluid biomarkers in HIV infection.Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.Intercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder.Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complexMechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis.Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsPursuit eye movement dysfunction in HIV-1 seropositive individuals.Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.Cerebrospinal fluid ferritin in HIV infected patients with acute neurological episodes.Diffusion alterations in corpus callosum of patients with HIV.Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centreComparison of scales to evaluate the progression of HIV-associated neurocognitive disorder.HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 CohortAIDS Dementia and HIV-1-Induced Neurotoxicity: Possible Pathogenic Associations and Mechanisms.HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatmentDevelopment of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment.A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.Adjuvant therapies for HIV-associated neurocognitive disorders.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation.Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot studyPersistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatmentMinocycline treatment for HIV-associated cognitive impairment: results from a randomized trialAPOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.HIV leucoencephalopathy and TNFalpha expression in neurones.
P2860
Q24810504-FA05D4BA-504F-49D6-8D76-D12A9AB6DDB0Q28066725-FCB6A3F8-B707-44D1-A85E-10778630FEDBQ28469174-09D734D9-57BE-44C8-ADB2-233614A1A205Q28475360-500E0976-1279-4F7F-99AD-52BCFB78D287Q30331833-A66EDE1C-0AB0-4132-B04A-6AB33BCC3FDAQ30445074-71223A35-253A-4C88-A185-960A306CFFDCQ30569766-5790A2DD-AACC-4D40-B480-644B722ECD6CQ31048720-24A1CE90-3182-421D-BD56-6BABF1ACE7E6Q31155550-D50D8EDE-C82A-4ED4-8AF4-E8D4A7A325B9Q33237758-CCA39EBD-45D5-4095-AD48-08AED246C7A2Q33257724-44053651-432E-4166-9041-678F748D0D6DQ33520347-F843F843-ADA3-44D3-A1FF-2D72B808F0D6Q33600252-10FAACC0-666D-4FD7-900B-A4C902E97BDFQ33699222-C26E7E2B-F2A4-4D28-B7EB-139A5849E827Q33710923-1903B32A-CDC8-487F-AAEB-FE468A272051Q33714228-D4F8B11A-AE08-44A4-B087-DCDAC6A0426FQ33732728-8CA5D76F-F8B7-4173-9394-991017666223Q33770575-908EBE48-91A8-411D-8301-617B5C682C46Q33785277-5DF80BC1-5359-4590-A25D-B2488A3B3416Q33785357-E9BA2713-3FF6-43BA-AF73-333AD36C7B2CQ33920969-BE12605D-F904-4824-AF3E-A35DAC6E8A40Q33933507-411DDE5E-F64F-4A95-9CE6-BDE910A00995Q33936659-96F282CB-EF17-4A9C-AB68-C2AE69E62BD8Q33984510-A5B929E7-5D0F-4D39-88FE-F63B7266367FQ34065983-B0BBE092-7D9A-4C4C-B7C2-8E66024AA4E1Q34103216-2ECE069A-2762-41B8-85DB-39D1F67B7E5BQ34135328-1F0AFA22-ABB9-4161-960A-3401D95400B5Q34406750-B9B1EF49-D3EF-4E19-AB36-E83C6EEFDBD9Q34450077-C07760C8-F994-4244-9F78-EF81B9919A3EQ34644242-194990C4-2E80-4A52-80DE-2196664776E9Q34671618-15C6D919-D29B-48DE-BC2E-60FCCCBD2A1FQ34685180-379CFBA8-98E0-4E3A-AC8E-94B8EAA7C3A1Q34692081-2D3DC268-0B46-43E1-BAB7-59A1D12D5B97Q34776835-57F8A684-660A-4561-8E8A-7DA7C57CACB7Q34958706-5AC7B3B2-7E52-4B16-BBC5-FB26E2DF8BD6Q35052651-B9AE96A0-8C22-46D0-B5BF-B70D4CAECC03Q35078313-4C22AB2F-0FCA-4520-B83E-457C74187553Q35215604-B916EA8E-C0C3-40FA-BCC5-CA5BA4288634Q35276365-3BAB9B6A-40E4-47E9-8317-08A96D374CCAQ35488817-F6179506-8712-4F0C-956E-3DC6EDD02AE4
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The AIDS dementia complex.
@en
The AIDS dementia complex.
@nl
type
label
The AIDS dementia complex.
@en
The AIDS dementia complex.
@nl
prefLabel
The AIDS dementia complex.
@en
The AIDS dementia complex.
@nl
P356
P1476
The AIDS dementia complex.
@en
P2093
P304
P356
10.1093/INFDIS/158.5.1079
P407
P577
1988-11-01T00:00:00Z